Manager, Disease Strategy Finance

Vertex Pharmaceuticals

Boston (MA)

On-site

USD 116,000 - 174,000

Full time

12 days ago
Application generator

An application made for this job — a tailored resume and cover letter that speak straight to the posting.

Get past ATS filters

Job summary

Vertex Pharmaceuticals is seeking a Manager, Disease Strategy Finance to provide rigorous financial analysis and strategic insights for Disease Strategy Teams. You will lead alliance financials, model development, and forecasting to guide decisions across R&D, manufacturing and commercialization.

The role partners with the global CFO organization and supports internal and external collaborations. The position emphasizes collaboration, accuracy, and actionable financial guidance to drive growth

Qualifications

  • B.S. Degree in Finance, Economics, or related quantitative/analytical field; MBA preferred.
  • 5+ years of relevant finance and industry experience - Biotechnology/Pharmaceutical industry experience strongly preferred.
  • Experience with biopharma alliance/collaboration accounting preferred though not required.
  • Understanding of biopharmaceutical drug R&D, manufacturing, and commercialization required.
  • Exceptional analytical and financial skills to evaluate a broad range of financial questions - valuation, ROI/ROIC, and complex multi-disciplinary business decisions.
  • Experience with Excel and PowerPoint; Hyperion or multidimensional databases a plus.

Responsibilities

  • Prepare a wide range of financial analyses to inform DST decisions on investments.
  • Lead preparation of alliance/collaboration financials for revenue/cost sharing in accordance with co-development/co-commercialization contract terms.
  • Develop and maintain financial models covering all aspects of biopharmaceutical research, development, manufacturing, and commercialization.
  • Provide Strategy Finance input into regular financial planning processes (Annual Budget, Forecasts, Long-Range Plan) for assigned Disease Areas.
  • Manage Disease Area P&Ls for assigned DSTs, including ensuring consistent presentation of DST finances across Vertex, explanation of variances vs. forecasts, risks/uncertainties, and opportunities for mitigation.
  • Prepare a wide range of presentations for cross-functional stakeholders and senior leaders.
  • Collaborate throughout CFO organization to identify and deliver on process improvement opportunities.

Skills

Financial analysis
Valuation
Cross-functional collaboration
Communication skills
Attention to detail

Education

B.S. Degree in Finance/Economics or related field
MBA preferred

Tools

Excel
PowerPoint
Hyperion

Job description

Job Description

The Manager, Disease Strategy Finance is a key member of Vertex's Disease Strategy Finance Team, providing financial and strategic insights to inform Disease Strategy Teams ("DSTs") on key decisions. This role will work closely with Directors on the DST Finance team to conduct financial modeling, forecasting, and scenario-based valuations. The Manager, Disease Strategy Finance will also play a critical role in creation of the Annual Budget, Long-Term Plan (LRP), and other financial forecasts in collaboration with colleagues. The role will partner closely with members of the global COFO organization, including finance teams supporting R&D, Biopharmaceutical Sciences and Manufacturing, Corporate, and Commercial. This role offers an opportunity to make a lasting impact by driving profitable growth while creating transformative medicines for people with serious diseases.

Position Summary:

Reporting to the Senior Director, Finance - Disease Strategy Teams, the Manager is a key member of Vertex's Strategy Finance team and the global FP&A organization. This role will lead financial analysis required to inform Disease Strategy Teams ("DSTs") on key decisions. Financial analyses will include financial modeling, forecasting, and scenario-based valuations. The Manager FP&A, Strategy Finance will also play a critical role in creating the Annual Budget, Long-Term Plan (LRP), and other financial forecasts. The role will be primary lead for preparation of collaboration financials for both internal and external partner reporting. The role will partner closely with members of the global CFO organization, including finance teams supporting R&D, Biopharmaceutical Sciences and Manufacturing, and Commercial. This role offers an opportunity to make a lasting impact by driving profitable growth while creating transformative medicines for people with serious diseases.

Key Responsibilities:
  • Prepare a wide range of financial analyses to inform DST decisions on investments.
  • Lead preparation of alliance/collaboration financials for revenue/cost sharing in accordance with co-development/co-commercialization contract terms.
  • Develop and maintain financial models covering all aspects of biopharmaceutical research, development, manufacturing, and commercialization.
  • Provide Strategy Finance input into regular financial planning processes (Annual Budget, Forecasts, Long-Range Plan), for assigned Disease Areas.
  • Manage Disease Area P&Ls for assigned DSTs, including ensuring consistent presentation of DST finances across Vertex, explanation of variances vs. forecasts, identification of risks/uncertainties, and opportunities for mitigation.
  • Prepare a wide range of presentations for cross-functional stakeholders and senior leaders.
  • Collaborate throughout CFO organization to identify and deliver on process improvement opportunities.
Qualifications:
  • B.S. Degree in Finance, Economics, or related quantitative/analytical field; MBA preferred.
  • 5+ years of relevant finance and industry experience - Biotechnology/Pharmaceutical industry experience strongly preferred.
  • Experience with biopharma alliance/collaboration accounting preferred though not required.
  • Understanding of biopharmaceutical drug research, development, manufacturing, and commercialization required.
  • Exceptional analytical and financial skills to evaluate a broad range of financial questions - especially valuation, ROI/ROIC, and complex multi-disciplinary business decisions.
  • Experience with Excel and PowerPoint; Experience with Hyperion (or another multidimensional database), business intelligence or visualization tools a plus.
  • Proficient business acumen, judgment and knowledge of the company's markets/products and industry trends.
  • Strong communication skills, both written and verbal, and an eagerness to collaborate with colleagues (within or outside of finance) in sharing insights and learnings. Must be able to work well with senior leaders, peers, and junior team members.
  • Possesses a high degree of attention to detail and ownership over work product with the flexibility to adapt to change.

#HYBRID

#LI-MF1

Pay Range:

$116,000 - $174,000

Disclosure Statement:

The range provided is based on what we believe is a reasonable estimate for the base salary pay range for this job at the time of posting. This role is eligible for an annual bonus and annual equity awards. Some roles may also be eligible for overtime pay, in accordance with federal and state requirements. Actual base salary pay will be based on a number of factors, including skills, competencies, experience, and other job-related factors permitted by law.

At Vertex, our Total Rewards offerings also include inclusive market-leading benefits to meet our employees wherever they are in their career, financial, family and wellbeing journey while providing flexibility and resources to support their growth and aspirations. From medical, dental and vision benefits to generous paid time off (including a week-long company

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Manager, Disease Strategy Finance
Manager, Disease Strategy Finance

Vertex Inc. • Boston (MA)

Hybrid
USD 116,000 - 174,000
Hybrid-Eligible
On-Site Eligible
Manager, Disease Strategy Finance
Manager, Disease Strategy Finance

Vertex Pharmaceuticals Incorporated • Boston (MA)

Hybrid
USD 116,000 - 174,000
Manager, Disease Strategy Finance
Manager, Disease Strategy Finance

Vertex Pharmaceuticals LLC • Boston (MA), Northern (KY)

Hybrid
USD 116,000 - 174,000
Annual bonus and equity awards
Hybrid-eligible or on-site work design
Director, Disease Strategy Finance
Director, Disease Strategy Finance

Vertex Pharmaceuticals • Boston (MA)

On-site
USD 181,000 - 271,000
Annual bonus
Equity awards
Strategic FP&A Manager, Disease Finance – Hybrid
Strategic FP&A Manager, Disease Finance – Hybrid

Vertex Pharmaceuticals Incorporated • Boston (MA)

Hybrid
USD 116,000 - 174,000
Strategic FP&A Manager, Disease Finance
Strategic FP&A Manager, Disease Finance

Vertex Inc. • Boston (MA)

Hybrid
USD 116,000 - 174,000
Hybrid-Eligible
On-Site Eligible
FP&A Manager, Disease Strategy & Growth
FP&A Manager, Disease Strategy & Growth

Vertex Pharmaceuticals • Boston (MA)

Hybrid
USD 116,000 - 174,000
Director, Disease Strategy Finance
Director, Disease Strategy Finance

Vertex Pharmaceuticals Inc (US) • Boston (MA)

Hybrid
USD 181,000 - 271,000
Strategic Finance Manager, Disease Strategy (Hybrid)
Strategic Finance Manager, Disease Strategy (Hybrid)

Vertex Pharmaceuticals LLC • Boston (MA), Northern (KY)

Hybrid
USD 116,000 - 174,000
Annual bonus and equity awards
Hybrid-eligible or on-site work design
Senior Director, Disease Strategy Finance & Analytics
Senior Director, Disease Strategy Finance & Analytics

Vertex Pharmaceuticals Inc (US) • Boston (MA)

Hybrid
USD 181,000 - 271,000